Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: Is there a real connection? the first case-control study

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 3, 2009, Pages 340-347

  De Larrañaga, Gabriela ^a,b   Bottaro, Edgardo ^c   Martinuzzo, Marta ^e   Figueroa, Raúl ^d   Iglesias Varela, María Luisa ^e   Perés Wingeyer, Silvia ^a   Forastiero, Ricardo ^e   Adamczuk, Yolanda ^e   Corti, Marcelo ^b   Puga, Liliana ^b   Benetucci, Jorge ^b  

^a Hemostasis and Thrombosis Laboratory   (Argentina)

^b HOSPITAL F J MUÑIZ   (Argentina)

^c Helios Salud ^*  (Argentina)

^d Hospital Santojanni Buenos Aires   (Argentina)

^e FAVALORO UNIVERSITY   (Argentina)

Author keywords

Antiphospholipid antibodies; CD4; Corticoid; HIV; Osteonecrosis; Thrombophilia

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CORTICOSTEROID;

ADULT; ARTICLE; AVASCULAR NECROSIS; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG UTILIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA;

ADRENAL CORTEX HORMONES; ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ODDS RATIO; OSTEONECROSIS; RISK ASSESSMENT; RISK FACTORS; THROMBOPHILIA;

EID: 66249106395     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607310217     Document Type: Article

References (40)

1. Chids SG Osteonecrosis. Orthop Nurs. 2005 ; 24: 295-301.
2. Hungerford DS, Jones LC Asymptomatic osteonecrosis. Should be treated Clin Orthop. 2004 ; 429: 124-130.
3. Cherian SF, Laorr A., Saleh KJ, et al. Quantifying the extent of femoral head involvement in osteonecrosis. J Bone Joint Surg Am. 2003 ; 85: 309-315.
4. Koller E., Mann M., Malozowski S., et al. Aseptic necrosis in HIV seropositive patients: a possible etiologic role for megestrol acetate. AIDS Patient Care STDs. 2000 ; 14: 405-410.
5. Glueck CJ, Freiberg RA, Fontaine RN, et al. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop. 2001 ; 386: 10-33.
6. Glueck CJ, Freiberg RA, Wang P. Role of thrombosis in osteonecrosis. Current Hematol Rep. 2003 ; 2: 417-422.
7. Keruly JC, Chaisson RE, Moore RD Increasing incidence of avascular necrosis of the hip in HIV-infected patients. J Acquir Immune Defic Syndr. 2001 ; 28: 101-102.
8. Brown P., Crane L. Avascular necrosis of bone in patients with human immunodeficiency virus infection: review of the literature. Clin Infect Dis. 2001 ; 32: 1221-1226.
9. Miller KD, Masur H., Jones EC, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med. 2002 ; 137: 17-24.
10. Gaughan DM, Mofenson LM, Hughes MD, et al. Osteonecrosis of the hip (Legg-Calvé-Perthes Disease) in human immunodeficiency virus-infected children. Pediatrics. 2002 ; 109: E74.
11. Thomas J., Doherty SM HIV infection: a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003 ; 33: 281-291.
12. Hasse B., Ledergerber B., Egger M., et al. Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV cohort study: a nested case-control study. AIDS Res Hum Retroviruses. 2004 ; 20: 909-915.
13. Molia AC, Strady C., Rouger C., et al. Osteonecrosis in six HIV-Infected patients receiving highly active antiretroviral therapy. Ann Phamacother. 2004 ; 38: 2050-2054.
14. Calza L., Manfredi R., Mastroianni A., et al. Osteonecrosis and highly active antiretroviral therapy during HIV infection: report of a series and literature review. AIDS Patient Care STDs. 2001 ; 15: 385-389.
15. Bottaro E., Figueroa RH, Scapellato P., et al. Osteonecrosis en pacientes infectados por HIV. Medicina. 2004 ; 64: 325-331.
16. Scribner AN, Trota-Cancio PV, Cox BA, et al. Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr. 2000 ; 25: 19-25.
17. Gutiérrez F., Padilla S., Ortega E., et al. Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors. J Acquir Immune Defic Syndr. 2002 ; 16: 481-495.
18. Mahoney CR, Glesby MJ, DiCarlo EF, et al. Total hip arthroplasty in patients with human immunodeficiency virus infection. Acta Orthop. 2005 ; 76: 198-203.
19. Panayotakopoulos GD, Day S., Peters BS, et al. Severe osteoporosis and multiple fractures in an AIDS patient treated with short-term steroids for lymphoma: a need for guidelines. Int J STD AIDS. 2006 ; 17: 567-568.
20. Amorosa V., Tebas P. Bone disease and HIV infection. Clin Infect Dis. 2006 ; 42: 108-114.
21. de Larrañaga G., Forastiero R., Carreras LO, et al. Different types of antiphospholipid antibodies in AIDS. A comparison with syphilis and the antiphospholipid syndrome. Thromb Res. 1999 ; 96: 19-25.
22. Jones LC, Mont MA, Le TB, et al. Procoagulants and osteonecrosis. J Rheumatol. 2003 ; 30: 783-791.
23. de Larrañaga G., Perés S., Puga L., et al. Association between the acquired free protein S deficiency in HIV-infected patients with the lipid profile levels. J Thromb Haemost. 2004 ; 2: 1195-1197.
24. Cervera R., Asherson RA, Acevedo ML, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis. 2004 ; 63: 1312-1317.
25. de Larrañaga G., Galich A., Puga L., et al. Insulin resistance status is an important determinant of PAI-1 levels in HIV infected patients, independently of the lipid profile. J Thromb Haemost. 2004 ; 2: 532-534.
26. de Larrañaga G., Bocassi A., Puga L., et al. Endothelial markers and HIV infection in the era of highly active antiretroviral treatment. Thromb Res. 2003 ; 110: 93-98.
27. Vasoo S., Sangle S., Zain M., et al. Orthopedic manifestation of the antiphospholipid (Hughes) syndrome. Lupus. 2005 ; 14: 339-345.
28. Tektonidou MG, Malagari K., Vlachoyiannopoulos PG, et al. Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use. Arthritis Rheum. 2003 ; 48: 732-736.
29. Ramos-Casals M., Cervera R., Lagrutta M., et al. Clinical feature related to antiphospholipid syndrome in patients with chronic viral infections (Hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis. 2004 ; 38: 1009-1016.
30. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306.
31. Calder JDF, Buttery L., Revell PA, et al. Apoptosis-a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004: 86: 1209-1213.
32. Nagasawa K., Tada Y., Koarada S., et al. Very early development of steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus. 2005 ; 14: 385-390.
33. Ichiseki T., Kaneuji A., Katsuda S., et al. DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology. 2005 ; 44: 456-460.
34. Kabata T., Kubo T., Matsumoto T., et al. Onset of steroid-induced osteonecrosis in rabbits an dits relationship to hyperlipaemia and increased free fatty acids. Rheumatology. 2005 ; 44: 1233-1237.
35. Motomura G., Yamamoto T., Miyanishi K., et al. Combined effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum. 2004 ; 50: 3387-3391.
36. Gutierrez F., Padilla S., Masiá M., et al. Osteonecrosis in patients infected with HIV: clinical epidemiology and natural history in a large case series from Spain. J Acquir Immune Defic Syndr. 2006 ; 42: 286-292.
37. Mary-Krause M., Billaud E., Poizot-Martin I., et al. Clinical Epidemiology Group of the French Hospital Database. Risk factor for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy. AIDS. 2006 ; 20: 1627-1635.
38. Lawson-Ayayi S., Bonnet F., Bernardin E., et al. Avascular necrosis in HIV-infected patients: a case-control study from the Aquitaine cohort, 1997-2002, France. Clin Infect Dis. 2005 ; 40: 1188-1193.
39. Skiest DJ Osteonecrosis in human immunodeficiency virus-infected patients may not be related to immune reconstitution. Clin Infect Dis. 2001 ; 33: 268-270.
40. Tektonidou MG, Moutsopoulos HM Immunologic factors in the pathogenesis of osteonecrosis. Orthop Clin N Am. 2004 ; 35: 259-263.